机器人胃切除术对进展期胃癌比早期胃癌更有益:基于倾向性评分匹配与腹腔镜胃切除术的比较
本研究比较机器人胃切除术(RG)与腹腔镜胃切除术(LG)在cStage I和cStage II/III胃癌中的手术与生存结局,经倾向性评分匹配后cStage II/III为118对、cStage I为113对。cStage II/III中RG组Clavien-Dindo分级≥III的腹腔内并发症显著少于LG组(LG=8.5% vs RG=1.7%,P=0.033),LG为独立危险因素(OR 5.69,95%CI 1.17-27.70,P=0.031);cStage I中两组手术结局无差异,两个分期中生存结局均无差异。
要点
- cStage II/III中RG组Clavien-Dindo分级≥III腹腔内并发症为1.7%,低于LG组的8.5%(P=0.033)。
- cStage II/III多因素分析显示LG为C.D.分级≥III腹腔内并发症的独立危险因素(OR 5.69,95%CI 1.17-27.70,P=0.031)。
- cStage I中LG与RG的手术结局无差异,两个分期中LG与RG的生存结局均无差异。
核心结论
- RG的实际获益体现在手术结局,尤其是进展期胃癌。
研究设计与样本
- 研究纳入cStage II/III患者299例(LG 170例,RG 129例)和cStage I患者569例(LG 455例,RG 114例),分别接受LG或RG。
- 对RG与LG进行倾向性评分匹配后,cStage II/III选出118对,cStage I选出113对。
- 分别对cStage II/III和cStage I比较LG与RG的手术结局和生存结局。
主要发现
- cStage II/III中,RG组Clavien-Dindo分级≥III的腹腔内并发症显著少于LG组(LG=8.5% vs RG=1.7%,P=0.033)。
- cStage II/III多因素分析确定LG为C.D.分级≥III腹腔内并发症的独立危险因素(OR 5.69,95%CI 1.17-27.70,P=0.031)。
- cStage I中未观察到LG与RG之间手术结局的差异。
- cStage I和cStage II/III中均未观察到LG与RG之间生存结局的差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gastric cancer is the fifth most prevalent malignancy globally and the fourth major contributor to cancer-related mortality. The comparative effectiveness of robotic gastrectomy (RG) versus laparoscopic gastrectomy (LG) at different stages of gastric cancer is unclear regarding surgical and survival outcomes. We compared surgical and survival outcomes between RG and LG in early-stage (cStage I) and advanced (cStage II/III) gastric cancers to elucidate the difference in the efficacy of RG across various stages of gastric cancer. METHODS: We identified 299 patients (LG, 170; RG, 129) with cStage II/III disease and 569 (LG, 455; RG, 114) with cStage I disease who underwent either LG or RG. Following propensity score matching for RG and LG, 118 pairs were selected for cStage II/II and 113 pairs for cStage I. Surgical and survival outcomes of LG and RG were separately compared for cStage II/III and cStage I. RESULTS: In cStage II/III, RG showed significantly fewer intra-abdominal complications of Clavien-Dindo (C.D.) Grade ≥ III in the RG group than in the LG group (LG = 8.5 vs. RG = 1.7%, P = 0.033). Multivariate analysis identified LG as an independent risk factor for intra-abdominal complications of C.D. Grade ≥ III (OR 5.69, 95% CI 1.17-27.70, P = 0.031). However, in cStage I, no difference in surgical outcomes between LG and RG was observed. No differences were observed in survival outcomes between LG and RG in both cStage I or cStage II/III. CONCLUSIONS: The real benefit of RG was demonstrated in surgical outcomes, especially for advanced-stage gastric cancer.
引用
- Kuwabara S, Kobayashi K, Sudo N, et al. Robotic gastrectomy is more beneficial for advanced than early-stage gastric cancer: a comparison with laparoscopic gastrectomy using propensity score matching. Surg Endosc. 2024. PMID: 38806954. doi:10.1007/s00464-024-10905-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。